Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 3967.77% is 1522% above its 5-year average of -278.98%, around the middle of its 5-year range (-1557.52%–13798.61%).
32.37% above its 12-month average of 2997.38%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -812.35%.
NET PROFIT MARGIN
3967.77%
NET PROFIT MARGIN AVG TTM
2997.38%
NET PROFIT MARGIN AVG 3Y
-235.84%
NET PROFIT MARGIN AVG 5Y
-278.98%
NET PROFIT MARGIN AVG 10Y
-112.53%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+32.37%
CURRENT VS 3Y AVG
+1782.37%
CURRENT VS 5Y AVG
+1522.24%
CURRENT VS 10Y AVG
+3625.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 740 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Kyntra Bio, Inc.
Market Cap
$24.38M
Net Profit Margin
3967.77%
TTM Avg
2997.38%
3Y Avg
-235.84%
5Y Avg
-278.98%
Market Cap
$24.68M
Net Profit Margin
0.00%
TTM Avg
-481.06%
3Y Avg
-1941.22%
5Y Avg
-2233.39%
Market Cap
$24.74M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$22.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$26.11M
Net Profit Margin
-974.68%
TTM Avg
-561.03%
3Y Avg
-287.02%
5Y Avg
-224.14%
Market Cap
$26.28M
Net Profit Margin
-355.17%
TTM Avg
-499.98%
3Y Avg
-419.63%
5Y Avg
-405.79%
Market Cap
$22.31M
Net Profit Margin
-24.76%
TTM Avg
-22.59%
3Y Avg
-21.34%
5Y Avg
-47.79%
Market Cap
$21.44M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyntra Bio, Inc. (KYNB) | $24.38M | 3967.77% | 2997.38% | -235.84% | -278.98% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.68M | 0.00% | -481.06% | -1941.22% | -2233.39% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| iTonic Holdings Ltd. (ITOC)vs › | $26.11M | -974.68% | -561.03% | -287.02% | -224.14% |
| LeonaBio, Inc. (LONA)vs › | $22.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| InspireMD, Inc. (NSPR)vs › | $26.28M | -355.17% | -499.98% | -419.63% | -405.79% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.31M | -24.76% | -22.59% | -21.34% | -47.79% |
| Modular Medical, Inc. (MODD)vs › | $21.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.60M | -1192.94% | 360.96% | 180.48% | 68.06% |
Operating Margin
-712.7%
Net Profit Margin
3967.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -812.35% |
| 2026-03-31 | -406.58% |
| 2025-12-31 | 2971.26% |
| 2025-09-30 | 13798.61% |
| 2025-06-30 | -564.02% |
| 2025-03-31 | 169.37% |
| 2024-12-31 | -14.59% |
| 2024-09-30 | -36.87% |
| 2024-06-30 | -1557.52% |
| 2024-03-31 | -129.84% |
| 2023-12-31 | -207.21% |
| 2023-09-30 | -158.51% |
| 2023-06-30 | -197.84% |
| 2023-03-31 | -212.12% |
| 2022-12-31 | -192.55% |
| 2022-09-30 | -582.46% |
| 2022-06-30 | -243.66% |
| 2022-03-31 | -103.91% |
| 2021-12-31 | -810.49% |
| 2021-09-30 | 31.93% |
| 2021-06-30 | -549.94% |
| 2021-03-31 | -186.72% |
| 2020-12-31 | -90.21% |
| 2020-09-30 | 74.95% |
| 2020-06-30 | -198.92% |
| 2020-03-31 | -321.09% |
| 2019-12-31 | -1230.54% |
| 2019-09-30 | -149.03% |
| 2019-06-30 | 60.56% |
| 2019-03-31 | -190.30% |
| 2018-12-31 | 19.39% |
| 2018-09-30 | -146.61% |
| 2018-06-30 | -53.29% |
| 2018-03-31 | -129.67% |
| 2017-12-31 | -52.04% |
| 2017-09-30 | -138.37% |
| 2017-06-30 | -114.44% |
| 2017-03-31 | -123.32% |
| 2016-12-31 | -106.55% |
| 2016-09-30 | -80.24% |
| 2016-06-30 | 27.24% |
| 2016-03-31 | -98.44% |
| 2015-12-31 | -210.17% |
| 2015-09-30 | -230.82% |
| 2015-06-30 | 47.33% |
| 2015-03-31 | -284.50% |
| 2014-12-31 | -313.94% |
| 2014-09-30 | -289.38% |
| 2014-06-30 | 52.06% |
| 2014-03-31 | -90.85% |
| 2013-12-31 | -216.09% |
| 2013-09-30 | 55.16% |
| 2013-06-30 | -59.24% |
| 2013-03-31 | -640.68% |
